Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tubaro

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Current Opinion in Urology|March 22, 2000
The use of voiding studies (flowmetry and urodynamics) in the assessment and follow-up of patientsA Tubaro
Journal of Endourology|November 18, 2000
Relation between intraprostatic temperature and clinical outcome in microwave thermotherapyS Carter, A Tubaro
European Urology|November 24, 1999
Management of symptomatic BPH in Italy: who is treated and how?A Tubaro, E Montanari
World Journal of Urology|June 21, 2002
Case selection for high-energy transurethral microwave thermotherapyA Tubaro, F C d'Ancona
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 26, 2005
[Overactive bladder: modulating the effects of antimuscarinic therapy]G Palleschi, A Tubaro, L Miano
Rivista Di Neurologia|September 1, 1981
[Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them]R Della Loggia, A Tubaro, C Redaelli
Natural Toxins|December 21, 2000
Methodological improvement of the protein phosphatase inhibition assay for the detection of okadaic acid in musselsR Della Loggia, S Sosa, A Tubaro
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 1, 1989
[Dermatotoxicity caused by Chrysaora hysoscella. Presentation of a case]F Kokelj, P Del Negro, A Tubaro
Drugs of Today (Barcelona, Spain : 1998)|November 25, 2016
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasiaC De Nunzio, F Presicce, A Tubaro
European Urology|December 9, 2000
Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials?A Tubaro, C Vicentini, R Renzetti, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Current Opinion in Urology|March 22, 2000
The use of voiding studies (flowmetry and urodynamics) in the assessment and follow-up of patientsA Tubaro
Journal of Endourology|November 18, 2000
Relation between intraprostatic temperature and clinical outcome in microwave thermotherapyS Carter, A Tubaro
European Urology|November 24, 1999
Management of symptomatic BPH in Italy: who is treated and how?A Tubaro, E Montanari
World Journal of Urology|June 21, 2002
Case selection for high-energy transurethral microwave thermotherapyA Tubaro, F C d'Ancona
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 26, 2005
[Overactive bladder: modulating the effects of antimuscarinic therapy]G Palleschi, A Tubaro, L Miano
Rivista Di Neurologia|September 1, 1981
[Evaluation of the activity on the mouse CNS of several plant extracts and a combination of them]R Della Loggia, A Tubaro, C Redaelli
Natural Toxins|December 21, 2000
Methodological improvement of the protein phosphatase inhibition assay for the detection of okadaic acid in musselsR Della Loggia, S Sosa, A Tubaro
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|June 1, 1989
[Dermatotoxicity caused by Chrysaora hysoscella. Presentation of a case]F Kokelj, P Del Negro, A Tubaro
Drugs of Today (Barcelona, Spain : 1998)|November 25, 2016
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasiaC De Nunzio, F Presicce, A Tubaro
European Urology|December 9, 2000
Invasive and minimally invasive treatment modalities for lower urinary tract symptoms: what are the relevant differences in randomised controlled trials?A Tubaro, C Vicentini, R Renzetti, et al.
Pageof 11